CytoMed TherapeuticsGDTC

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$22.7M

Market Cap • 25/07/2024

2018

(há 6 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of SG

Singapore

27

N° de Empregados • 2023

Valuation

Valuation Indicators

Retorno Histórico

GDTCSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-8%

1 dia

22/07/2024

-12%

1 semana

18/07/2024

-3%

1 mês

25/06/2024

-47%

1 ano

25/07/2023

10 anos

Histórico